A0636112
Allopurinol , 98% , 315-30-0
Synonym(s):
1H-Pyrazolo(3,4-d)pyrimidin-4-ol;4-Hydroxypyrazolo(3,4-d)pyrimidine;4-Hydroxypyrazolo[3,4-d]pyrimidine;Allopurinol;HPP
CAS NO.：315-30-0
Empirical Formula: C5H4N4O
Molecular Weight: 136.11
MDL number: MFCD00599413
EINECS: 206-250-9
| Pack Size | Price | Stock | Quantity |
| 5g | RMB28.80 | In Stock |
|
| 25G | RMB36.80 | In Stock |
|
| 100G | RMB130.40 | In Stock |
|
| 500G | RMB611.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >300 °C (lit.) |
| Boiling point: | 250.36°C (rough estimate) |
| Density | 1.4295 (rough estimate) |
| refractive index | 1.8500 (estimate) |
| storage temp. | 15-25°C |
| solubility | 1 M NaOH: soluble50mg/mL, clear to very slightly hazy, colorless to faintly yellow |
| form | Powder |
| pka | 10.2(at 25℃) |
| color | White or almost white |
| Water Solubility | 0.35 g/L (25 ºC) |
| Merck | 14,279 |
| BCS Class | 3,1 |
| InChIKey | OFCNXPDARWKPPY-UHFFFAOYSA-N |
| CAS DataBase Reference | 315-30-0(CAS DataBase Reference) |
| NIST Chemistry Reference | Allopurinol(315-30-0) |
| EPA Substance Registry System | Allopurinol (315-30-0) |
Description and Uses
Xanthine oxidase inhibitor; decreases uric acid production. Used in treatment of hyperuricemia and chronic gout. Antiurolithic
Safety
| Symbol(GHS) |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301-H317 |
| Precautionary statements | P280-P301+P310+P330-P302+P352 |
| Hazard Codes | T,Xi,Xn |
| Risk Statements | 25-43-36/37/38-20/21/22 |
| Safety Statements | 28-36/37-45-36/37/39-26-24-36 |
| RIDADR | UN 2811 6.1/PG 3 |
| WGK Germany | 2 |
| RTECS | UR0785000 |
| TSCA | Yes |
| HazardClass | 6.1 |
| PackingGroup | III |
| HS Code | 29335990 |
| Hazardous Substances Data | 315-30-0(Hazardous Substances Data) |
| Toxicity | LD50 oral in mouse: 78mg/kg |
